Finance

Lists
6821:HKG
Asymchem Laboratories (Tianjin) Co Ltd
HK$121.60
-5.00%
(-6.40) 1D
Aug 31, 4:08:46 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 6821...
Open
HK$125.00
High
HK$128.40
Low
HK$119.80
Mkt. cap
64.22B
Avg. vol.
0.00
Volume
715.18K
P/E ratio
33.47
52-wk high
HK$139.70
52-wk low
HK$69.20
EPS
HK$3.63
No. of employees
11K
Open
HK$125.00
High
HK$128.40
Low
HK$119.80
Mkt. cap
64.22B
Avg. vol.
0.00
Volume
715.18K
P/E ratio
33.47
52-wk high
HK$139.70
52-wk low
HK$69.20
EPS
HK$3.63
No. of employees
11K
About Asymchem Laboratories (Tianjin) Co Ltd
CEOHao Hong
Employees10.6K
FoundedOct 7, 1998
Headquarters-
SectorPharmaceutical industry
Websiteasymchem.com.cn
Last report
Aug 25, 2026
Fiscal period
Q2 2026
EPS / Est. (CNY)
- / -
Revenue / Est. (CNY)
1.80B / 1.88B
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.44B
2.04B
1.80B
1.80B
Cost of goods sold
850.56M
1.26B
1.03B
1.07B
Cost of revenue
850.56M
1.26B
1.03B
1.07B
Research and development expenses
147.32M
160.19M
126.99M
124.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
263.32M
242.33M
259.12M
255.40M
Operating expense
386.79M
492.26M
373.80M
414.47M
Total operating expenses
1.24B
1.75B
1.40B
1.49B
Operating income
204.22M
285.52M
401.28M
315.69M
Other non operating income
-54.15M
49.96M
-115.98M
123.76M
EBT including unusual items
209.85M
376.44M
333.37M
253.16M
EBT excluding unusual items
255.03M
302.11M
347.91M
273.40M
Income tax expense
30.52M
42.27M
32.21M
40.21M
Effective tax rate
14.55%
11.23%
9.66%
15.88%
Other operating expenses
-25.78M
52.60M
-14.90M
30.02M
Net income
182.77M
332.32M
304.32M
216.14M
Net profit margin
12.68%
16.29%
16.89%
11.97%
Earnings per share
-
-
-
-
Interest and investment income
77.34M
93.79M
65.57M
37.66M
Interest expense
-3.13M
-3.36M
-2.97M
-3.24M
Net interest expenses
74.22M
90.42M
62.60M
34.41M
Depreciation and amortization charges
-
-
-
-
EBITDA
317.01M
407.74M
523.51M
454.57M
Gain or loss from assets sale
25.14K
2.57M
-
4.40M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps